Scarica l'app Stockscreener
14.27
3.71%
0.51
Carlsmed Inc Borsa (CARL) Ultime notizie
Carlsmed, Inc. Announces Appointment of Tony Jarc as Chief Product and Ai Officer, Effective October 1, 2026 - marketscreener.com
Carlsmed Appoints Tony Jarc as Chief Product and AI Officer - Orthopedics This Week
Carlsmed appoints Tony Jarc as chief product and AI officer - Investing.com India
Form 4 Carlsmed Inc For: 30 September By Investing.com - Investing.com Nigeria
Stock awards for Carlsmed (CARL)'s CFO include 89,286 units and options exercisable at $14.18. - Stock Titan
[Form 3] CARLSMED, INC. Initial Statement of Beneficial Ownership - Stock Titan
Form 144 CARLSMED For: 30 September By Investing.com - Investing.com Nigeria
Carlsmed FY26 Results: Sales guidance affirmed at $74-78 million - scanx.trade
Carlsmed Inc (CARL-Q) Profile - The Globe and Mail
Carlsmed names new CFO - MedTech Dive
Carlsmed raises FY26 sales guidance to $74-78M range - scanx.trade
Carlsmed, Inc. Announces CFO Changes - marketscreener.com
Truist Securities raises Carlsmed price target to $20 on Buy rating - scanx.trade
Carlsmed, Inc. Reaffirms Revenue Guidance for the Full Year 2026 - marketscreener.com
Carlsmed (NASDAQ:CARL) Earns "Buy" Rating from BTIG Research - MarketBeat
BTIG reiterates Buy rating on Carlsmed, $23 price target - TradingView
Carlsmed appoints Richard Heppenstall as CFO - Investing.com
Carlsmed appoints new CFO, reaffirms 2026 revenue outlook - TradingView
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer - The Manila Times
Carlsmed, Inc.(NasdaqGS: CARL) added to S&P Global BMI Index - marketscreener.com
Presidio Management Group XII buys $3m in Carlsmed stock By Investing.com - Investing.com Nigeria
Presidio Management Group XII buys $3m in Carlsmed stock - Investing.com
Carlsmed files patent lawsuit against DeGen Medical By Investing.com - Investing.com Australia
Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical - The Manila Times
Carlsmed files patent lawsuit against DeGen Medical - Investing.com
Carlsmed Files Patent Infringement Lawsuit Against DeGen Medical Over Spine Surgery Technologies - Quiver Quantitative
Ten percent owner boosts stake in Carlsmed (CARL) - Stock Titan
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Carlsmed COO Jeffrey Bertolini Awarded 50,000 Stock Options with $15.23 Exercise Price - Kalkine Media
Carlsmed (CARL) awards COO 50,000 stock options - Stock Titan
Carlsmed (CARL) COO discloses 22,489-share stake - Stock Titan
Carlsmed, Inc. Announces Chief Operating Officer Appointment - The Manila Times
Carlsmed, Inc.: Shareholders Board Members Managers and Company Profile | US14280C1053 - marketscreener.com
Carlsmed appoints Jeff Bertolini as new COO - TipRanks
Carlsmed names Jeffrey Bertolini as Chief Operating Officer - TradingView
symbol__ Stock Quote Price and Forecast - cnn.com
BlackRock Inc. Purchases New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Jupiter Topco LLC Acquires New Holdings in Carlsmed, Inc. $CARL - MarketBeat
Wall Street Analysts Think Carlsmed, Inc. (CARL) Could Surge 90.77%: Read This Before Placing a Bet - qz.com
Parkman Healthcare Partners LLC Invests $6.20 Million in Carlsmed, Inc. $CARL - MarketBeat
Carlsmed (CARL) Earnings Snapshot: EPS Lands Above Forecast on the Day; The Stock Ends Down 1.56% in the Current UpdateBuyback Announcement Report - dars.gov.et
Carlsmed, Inc. (NASDAQ:CARL) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to "Hold" - MarketBeat
Carlsmed (CARL) plans up to $250M in stock, debt and warrant sales - Stock Titan
Carlsmed files prospectus to offer up to $250 million in securities - scanx.trade
Carlsmed (CARL) Holds Steady Near $13.72 as Tight Range Signals Potential MoveDefined Outcome ETF - vinanet.vn
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform - TradingView
Transcript : Carlsmed, Inc. Presents at Bank of America SMID Cap Virtual Conference, Aug-12-2026 11 - marketscreener.com
CARL: Personalized AI spine surgery platform accelerates growth with new reimbursement and strong clinical data - TradingView
CARL Q2 2026 Earnings: Narrower-Than-Expected Loss but Shares Slip 2.55%EPS Surprise History - careplusvn.com
Carlsmed, Inc. Common Stock (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - Kalkine
Carlsmed, Inc. (NASDAQ: CARL) Share Price, CARL Stock News, CARL Share Price & Updates - kalkine.ca
Truist raises Carlsmed stock price target on strong growth outlook By Investing.com - Investing.com South Africa
Carlsmed Buy Rating Reaffirmed as 2026 Outlook Raised and Adoption Grows; $17 Price Target Maintained - TipRanks
Analysts Are Bullish on These NA Stocks: BillionToOne, Inc. Class A (BLLN), Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed Q2 2026 revenue up 57% to USD 18.9M - Medical Buyer
Truist raises Carlsmed stock price target on strong growth outlook - Investing.com Nigeria
CARLSMED INC Q2 NET INCOME USD -10.5 MILLION - Moomoo
0.13%
2.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):